Pancreas dependant immunoassay for determining subpopulations of monoclonal antibodies to somatostatin.
US4764475A · kind A · utility
0Cited by
3References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 1, 1986 |
| Grant date | Aug 16, 1988 |
| Priority date | — |
| Expiry date | Dec 1, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/16
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A correlation has been demonstrated between the ability of an antibody to block the inhibitory action of somatostatin on the gastric inhibitory peptide(GIP)-stimulated release of insulin from the pancreas in vitro and the ability to stimulate growth in vivo. Antibodies which are identified in the GIP-stimulated insulin release assay are also capable of elevating the levels of growth hormone in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.